AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2007
Mar 26, 2007
29875_dirs_2007-03-26_c7df9cad-ed52-4b92-95c0-64a59c5da998.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS/CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2007-03-22
Reporting Person: BANKS EDWIN M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-03-22 | Common Stock | A | 24194 | $34.8 | Acquired | 24194 | Direct |
| 2007-03-22 | Common Stock | A | 11690 | $34.8 | Acquired | 35884 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-03-22 | Stock Option | $9.17 | A | 46849 | Acquired | 2013-02-25 | Common Stock (46849) | Direct |
| 2007-03-22 | Stock Option | $13.41 | A | 46856 | Acquired | 2014-01-02 | Common Stock (46856) | Direct |
| 2007-03-22 | Stock Option | $20.23 | A | 33739 | Acquired | 2015-03-01 | Common Stock (33739) | Direct |
| 2007-03-22 | Stock Option | $27.12 | A | 33726 | Acquired | 2016-03-01 | Common Stock (33726) | Direct |
Footnotes
F1: Shares acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of shares to CVS/Caremark Corporation common stock. Price reflects the opening price of CVS/Caremark Corporation common stock on the date of the merger.
F2: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3